Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Blood Profiling Reflects a Significant Down-Regulation in Oxidative Phosphorylation Following Renal Transplantation with DCD and AKI Allografts
S. Walker¹, L. Cox², C. Langefeld², B. Freedman², A. Farney², J. Rogers², C. Jay², R. Stratta², G. Orlando²
¹Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, ²Wake Forest Baptist Medical Center, Winston Salem, NC
*Purpose: The human kidney transplant (KT) patient provides a unique and compelling in situ model system to study molecular events that underlie graft recovery following…
2019 American Transplant Congress
Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients
M. Z. Molnar, O. Cseprekal, M. Yazawa, M. Talwar, V. Balaraman, V. Mas, D. Maluf, R. Helmick, L. Campos, N. Nezakatgoo, C. Eymard, P. Horton, R. Verma, A. Jenkins, C. R. Handley, H. Snyder, C. Cummings, U. A. Agbim, B. Maliakkal, S. K. Satapathy, S. P. Nair, J. D. Eason
Methodist University Hospital Transplant Institute, Memphis, TN
*Purpose: There are no data on the safety of kidney transplantation from hepatitis C (HCV) NAT positive donors to HCV naïve recipients. We report the…
2019 American Transplant Congress
Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients
P. R. Modi, B. Pal, S. Singla, R. Chauhan, V. Kothari, A. Mishra, M. Modi, B. Butala, V. Kute, H. Patel, V. Trivedi
Transplantation Surgery and Urology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India
*Purpose: Robotic Kidney Transplantation (RKT) is emerging modality of treatment for patient with end stage kidney diseases. It is accepted for obese recipients. However, there…
2019 American Transplant Congress
Eculizumab Deposition in Renal Transplants
D. WANG¹, S. H. Nasr¹, A. B. Farris², C. A. Schinstock³, M. P. Alexander¹, L. D. Cornell¹
¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, ²Pathology & Laboratory Medicine, Emory University, Atlanta, GA, ³Division of Nephrology & Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN
*Purpose: Eculizumab is a recombinant humanized IgG monoclonal antibody that inhibits C5, thereby preventing the activation of C5a and formation of membrane attack complex C5b-C9.…
2019 American Transplant Congress
Living Donor Conversion Rates as a Quality Measure for Kidney Program Efficiency for Both New Referrals and Existing Listed Candidates
E. Woodle¹, C. Siemers², B. Woodle³, C. King², R. Alloway¹, S. Tremblay¹
¹U of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH, ³U of Arkansas, Little Rock, AR
*Purpose: Arguably the most important achievement for renal failure patients is identification of a living donor (LD)and transplantation with a LD kidney. Given these considerations…
2019 American Transplant Congress
Dialysis Facility Profit Status and Referral for Kidney Transplantation
E. R. Walker¹, L. J. McPherson¹, J. C. Gander², S. Pastan¹, R. E. Patzer¹
¹Emory University School of Medicine, Atlanta, GA, ²Kaiser Permanente Georgia, Atlanta, GA
*Purpose: Patients receiving dialysis treatment in for-profit dialysis facilities have historically lower rates of kidney transplantation (KT) compared to non-profit facilities, but the impact of…
2019 American Transplant Congress
Assessment of Serum Tim3 and Gal9 Levels in Predicting the Risk of Infection after Kidney Transplantation
Y. Shi¹, y. li², Y. Li², L. Yan², J. Tang², X. Wu², Y. Bai², Y. An², B. Dai², C. Yang², L. Wang²
¹Department of Nephrology, West China Hospital, Chengdu, China, ²Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Infection remains a major cause of morbidity and mortality after kidney transplantation (KT). However, reliable biomarkers to predict the occurrence of post-transplant infection are…
2019 American Transplant Congress
Belatacept Monotherapy in Kidney Transplant Recipients with Failed Allografts Reduces Humoral Sensitization in a Single Center Randomized Controlled Trial
I. R. Badell, R. Elbein, R. A. Bray, H. M. Gebel, A. B. Adams, C. P. Larsen
Emory University School of Medicine, Atlanta, GA
*Purpose: Kidney transplant recipients with failed allografts suffer from high rates of humoral sensitization. Immunosuppression (IS) strategies are highly variable in these patients with many…
2019 American Transplant Congress
Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients
D. Puliyanda¹, R. D. Swinford², H. Pizzo¹, J. Garrison¹, I. Kim¹, A. M. De Golovine², S. Jordan¹
¹Pediatric Nephrology, Cedars-Sinai Med Ctr, Los Angeles, CA, ²Pediatric Nephrology, UTHealth, Houston, TX
*Purpose: A renal biopsy, the gold standard for the diagnosis of antibody mediated rejection (ABMR) in transplant recipients, is invasive and may be associated with…
2019 American Transplant Congress
Impact of Functional Delayed Graft Function in the Modern Era of Kidney Transplantation
D. Cucchiari, A. Molina-Andujar, E. Montagud-Marrahi, J. Rovira, F. Diekmann
Renal Transplant Unit, Hospital Clínic, Barcelona, Spain
*Purpose: the classical definition of Delayed Graft Function (DGF) (i.e. need of dialysis during the first week after kidney transplant) depends on the physician attitude…